StockData
Metagenomi Therapeutics, Inc. logo

Metagenomi Therapeutics, Inc. (MGX) stock

MGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.63−0.05 (-7.21%)

Close on Nov 17, 2026Market cap $23.84MP/E –Yield –

Metagenomi Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Metagenomi Therapeutics's market cap was $28.57M on Nov 11, 2026, against $65.71M a year earlier. Over the last 3 years it ranged from $23.90M to $239.05M, with a median of $63.55M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$28.57M-53.0%
2025Dec 31, 2025$60.83M-55.0%
2024Dec 31, 2024$135.13M–

More Metagenomi Therapeutics figures

See a number that looks wrong?